XENE logo

Xenon Pharmaceuticals (XENE) Non Current Assets

Annual Non Current Assets

$162.88 M
-$156.96 M-49.08%

December 31, 2024


Summary


Performance

XENE Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXENEbalance sheetmetrics:

Quarterly Non Current Assets

$162.88 M
-$13.39 M-7.59%

December 31, 2024


Summary


Performance

XENE Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXENEbalance sheetmetrics:

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

XENE Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-49.1%0.0%
3 y3 years+1154.1%+1209.0%
5 y5 years+5653.3%+1209.0%

XENE Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-49.1%+1154.1%-49.1%+1209.0%
5 y5-year-49.1%+5653.3%-49.1%+5653.3%
alltimeall time-49.1%>+9999.0%-49.1%>+9999.0%

Xenon Pharmaceuticals Non Current Assets History

DateAnnualQuarterly
Dec 2024
$635.26 M(-1.5%)
$162.88 M(-7.6%)
Sep 2024
-
$176.26 M(+13.0%)
Jun 2024
-
$155.92 M(-26.4%)
Mar 2024
-
$211.82 M(-33.8%)
Dec 2023
$644.96 M(+7.4%)
$319.84 M(+128.3%)
Sep 2023
-
$140.09 M(-0.1%)
Jun 2023
-
$140.28 M(-24.8%)
Mar 2023
-
$186.52 M(+21.2%)
Dec 2022
$600.30 M(+7.4%)
$153.85 M(+21.5%)
Sep 2022
-
$126.64 M(+906.9%)
Jun 2022
-
$12.58 M(+1.1%)
Mar 2022
-
$12.44 M(-4.2%)
Dec 2021
$559.02 M(+207.5%)
$12.99 M(+61.5%)
Sep 2021
-
$8.04 M(+1.0%)
Jun 2021
-
$7.96 M(+7.4%)
Mar 2021
-
$7.41 M(+0.1%)
Dec 2020
$181.78 M(+25.5%)
$7.40 M(+71.4%)
Sep 2020
-
$4.32 M(+17.8%)
Jun 2020
-
$3.67 M(+15.5%)
Mar 2020
-
$3.17 M(+12.1%)
Dec 2019
$144.87 M
$2.83 M(+16.7%)
Sep 2019
-
$2.43 M(-5.5%)
DateAnnualQuarterly
Jun 2019
-
$2.57 M(+2.6%)
Mar 2019
-
$2.50 M(+128.4%)
Dec 2018
$121.33 M(+170.7%)
$1.10 M(+13.9%)
Sep 2018
-
$962.00 K(-11.4%)
Jun 2018
-
$1.09 M(-1.4%)
Mar 2018
-
$1.10 M(-15.3%)
Dec 2017
$44.82 M(-31.8%)
$1.30 M(-5.2%)
Sep 2017
-
$1.37 M(-13.9%)
Jun 2017
-
$1.59 M(-3.2%)
Mar 2017
-
$1.65 M(-9.2%)
Dec 2016
$65.67 M(+7.9%)
$1.81 M(-10.3%)
Sep 2016
-
$2.02 M(-11.9%)
Jun 2016
-
$2.29 M(-20.4%)
Mar 2016
-
$2.88 M(-6.5%)
Dec 2015
$60.87 M(-28.3%)
$3.08 M(-19.5%)
Sep 2015
-
$3.83 M(+76.2%)
Jun 2015
-
$2.17 M(-7.6%)
Mar 2015
-
$2.35 M(-5.0%)
Dec 2014
$84.94 M(+70.3%)
$2.48 M(-57.9%)
Sep 2014
-
$5.88 M(+6.7%)
Jun 2014
-
$5.50 M(+19.2%)
Dec 2013
$49.87 M(-17.8%)
$4.62 M
Dec 2012
$60.70 M
-

FAQ

  • What is Xenon Pharmaceuticals annual long term assets?
  • What is the all time high annual non current assets for Xenon Pharmaceuticals?
  • What is Xenon Pharmaceuticals annual non current assets year-on-year change?
  • What is Xenon Pharmaceuticals quarterly long term assets?
  • What is the all time high quarterly non current assets for Xenon Pharmaceuticals?
  • What is Xenon Pharmaceuticals quarterly non current assets year-on-year change?

What is Xenon Pharmaceuticals annual long term assets?

The current annual non current assets of XENE is $162.88 M

What is the all time high annual non current assets for Xenon Pharmaceuticals?

Xenon Pharmaceuticals all-time high annual long term assets is $319.84 M

What is Xenon Pharmaceuticals annual non current assets year-on-year change?

Over the past year, XENE annual long term assets has changed by -$156.96 M (-49.08%)

What is Xenon Pharmaceuticals quarterly long term assets?

The current quarterly non current assets of XENE is $162.88 M

What is the all time high quarterly non current assets for Xenon Pharmaceuticals?

Xenon Pharmaceuticals all-time high quarterly long term assets is $319.84 M

What is Xenon Pharmaceuticals quarterly non current assets year-on-year change?

Over the past year, XENE quarterly long term assets has changed by $0.00 (0.00%)